[Application of HS221GI in treatment of influenza and ARVI in adults: a new approach - managing virus-induced inflammation. Results of a double-blind, randomized, placebo-controlled, multicenter clinical trial].
A G MalyavinM I BagaevaO V KalyuzhinPublished in: Terapevticheskii arkhiv (2023)
is an effective and safe treatment for influenza and other ARVI in adults.